Advertisement
U.S. Markets open in 3 hrs 57 mins

CHOSA Oncology AB (CHOSA.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
0.79000.0000 (0.00%)
As of 09:32AM CET. Market open.

CHOSA Oncology AB

Medicon Village AB
Lund 223 81
Sweden
46 7 37 51 72 78
https://www.chosaoncology.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 0

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Buhl Jensen Adj Professor, M.D., M.D., Ph.D., Ph.D.Chief Executive OfficerN/AN/A1955
Ms. Ulla Hald BuhlCOO & Board MemberN/AN/A1964
Mr. Claus Frisenberg PedersenChief Commercial Officer & Board MemberN/AN/A1972
Mr. Gerton JonssonChief Financial OfficerN/AN/A1971
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB incorporated in 2022 and is based in Lund, Sweden.

Corporate Governance

CHOSA Oncology AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.